The opportunity
Within Innovative medicine our ambition is to create a significant impact for people living with severe conditions and their caregivers by discovering, developing and delivering innovative medicine.
We are now looking for an European Value & Access Director to lead our European Innovative Medicine Value and Access in the assigned therapeutic area. In this pivotal role, you will be responsible for developing and implementing strategies that ensure patients in Europe can benefit from our innovative therapies.
The Value & Access Director is dedicated to co-developing innovative and winning market access strategies, optimizing the payer value proposition and access-relevant evidence packages for assets, in partnership with the cross-functional teams.
The Main Purpose Of The Value and Access Director
Define European Value and Access Strategy
With cross functional team , develop and deliver all aspects of access strategy and execution within the region
Enable asset strategy to translate science into payer and HCS value propositions and solutions, securing access, affordability, and contribute to wide scale patient access and efficiencies at scale.
Plays a critical leadership role in launch readiness, partnering across functions and key markets.
Ensure Cross Functional Collaboration
Represent access with internal partners and external stakeholders. Internally, drive vision, inspire and provide leadership throughout the Access community (Global, Regions, Countries) and with key partners.
Externally, represent Teva in appropriate fora and organizations to drive the company strategic access agenda.
Collaborate and partner with Commercial, Medical Affairs, Development and HEVO to enhance the value proposition, access strategy and access-relevant evidence packages.
With European Ix commercial organization, Pricing Analyst and Finance co-create the European pricing strategy and guidance in line with a Global pricing strategy. Ensure timely input into Global Pricing strategy for Europe.
Create collaborative partnerships internally and externally to break down silos, partner across the value chain and shape the future of healthcare and markets.
Act as a Thought leader within the Therapeutic Area
Create and champion a compelling and competitive international strategic vision for how IM will innovate and expand access through DAs for the benefit of patients, Healthcare Systems, Payers, and Teva
Active leadership - enable broad country insights and alignment, and leverage external environment (e.g., EMA/EUnetHTA & advisory boards) to pressure-test strategies, level of evidence etc. for feasibility and success.
Stay abreast of internal and external developments, trends and other dynamics that affect the wider health policy and access domains, as well as of relevant scientific, clinical, and commercial developments.
Analyze and anticipate changes in priority markets (EU4 +UK), major HTA archetypes (e.g., UK/FR/DE) and Budget Impact archetypes (e.g., Italy/Spain) to model future expenditures and project critical market access assumptions.
How you’ll spend your day
Develop and maintain the Integrated Access strategy per product throughout the product lifecycle which clearly articulates the product strategy and differentiation most relevant to payers (e.g., well-defined target population, clinical endpoints, comparators, outcome measures, utility instruments, Health Economics data), patients, and HCS stakeholders in Europe in line with Global access strategy.
Develop payer negotiation strategy, upskill and prepare countries for their payer negotiations.
Develop innovative patient access and contracting approaches, Managed Entry Agreements (MEAs) as required, to improve patient outcomes and support healthcare system affordability.
Ensure that at launch, Teva’s brands are supported by a robust payer value proposition particularly featuring core elements; ‘Value for money’ story, strong value evidence package and a pricing strategy maximizing the lifetime value of the brand (including existing and future evidence to justify price).
Ensure Access input is reflected in TPPs, clinical programs , BD&L assessments, asset maximization and indication sequencing
Identify evidence, in addition to registration studies, required to meet the needs of medical experts and institutions involved in reimbursement & access decisions for key markets.
Collaborate with the HEVO & Cross functional neuroscience Europe team to ensure full integration of adequate HEOR/evidence deliverables in high quality therapeutic area strategy.
Develop and rollout the “access toolbox” to share with countries, major HTA archetypes (e.g., UK/FR/DE) and Budget Impact archetypes (e.g., Italy/Spain)
In collaboration with international or regional policy groups, develop and rollout materials which communicate the value of Teva’s medicines to HCS decision-makers, with focus on international forums and publications
Manage Access community and budgets.
Your experience and qualifications
5+ years of experience in country market access roles
3+ years global or ex-US regional experience
Experience working early in drug development lifecycle
Product launch experience
BD&L access experience
Cross functional and matrix influential experience across a team of multiple stakeholders
Experience in driving commercial strategy driven through access or HEOR or pricing expertise
Desirable Requirements
2+ years of experience in the relevant therapeutic areas – neuroscience, immunology. Strong external network with thought leaders and influencers in the payer and HTA environment
MBA, Ph.D., M.D. or RPh
Location
Any Teva EU location
Make a difference with Teva Pharmaceuticals